Biotech Investment Firm Jeito Capital Launches with €200M Fund
The French investment firm Jeito Capital has launched this week with a €200M fund that…
16/01/2020 - 2 minutes
Trends & News
BioNTech Expands Cancer Portfolio With US Biotech Acquisition
German cancer specialist BioNTech will acquire US T-cell therapy biotech Neon Therapeutics in a deal…
16/01/2020 - 2 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
15/01/2020 - 2 minutes
Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing
Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene…
14/01/2020 - 3 minutes
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany
The US company bluebird bio has launched the first gene therapy for the blood disorder…
14/01/2020 - 3 minutes
KaNDy’s Menopause Treatment Tackles Hot Flashes in Phase II
A non-hormonal menopause treatment that targets the brain’s ‘thermostat’, developed by the UK company KaNDy…
13/01/2020 - 3 minutes
Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B
The French company Eyevensys has raised €27M to fund the launch of a phase II…
10/01/2020 - 3 minutes
Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development
The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round,…
09/01/2020 - 3 minutes
Therachon Founders Spin Out New Rare Disease Biotech With €31M Investment
The founders of Swiss biotech Therachon have launched a new company called VectivBio, also based…
08/01/2020 - 2 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
06/01/2020 - 2 minutes
€31M Series B Funds Rollout of Artificial Pancreas in Type 1 Diabetes
The French biotech Diabeloop has raised €31M to launch an artificial pancreas device designed to…
02/12/2019 - 3 minutes
CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
19/11/2019 - 3 minutes
